Prospective Assessment of Early Outcomes Following Thulium Fiber Laser Enucleation of the Prostate Using SOLTIVE™ SuperPulsed Laser Systems in an Asian Population - Takeaways - MDSpire

Prospective Assessment of Early Outcomes Following Thulium Fiber Laser Enucleation of the Prostate Using SOLTIVE™ SuperPulsed Laser Systems in an Asian Population

  • By

  • Brian W.H. Siu

  • David K.W. Leung

  • Rachel S.K. Wong

  • Chris H.M. Wong

  • Alex Q. Liu

  • Chi Hang Yee

  • Jeremy Y.C. Teoh

  • Peter K.F. Chiu

  • Chi Fai Ng

  • Ka Lun Lo

  • March 30, 2026

  • 0 min

Share

  • 1

    Thulium fiber laser enucleation of the prostate (ThuFLEP) shows early safety and feasibility in an Asian cohort with no Clavien-Dindo grade ≥3 complications.

  • 2

    The median operation time for ThuFLEP was 87 minutes, with a catheter-free rate of 87.5% on day 1 and 100% by day 14 post-surgery.

  • 3

    At 3 months, patients experienced significant improvements in urinary symptoms, with a median IPSS of 4 and median Qmax of 21.5 ml/s.

  • 4

    PSA levels significantly decreased from a median of 6.05 to 1.20 ng/ml at the 3-month follow-up, indicating effective prostate tissue ablation.

  • 5

    The study highlights the need for larger, multicenter trials to further validate the safety and efficacy of ThuFLEP in diverse populations.

Original Source(s)

Prospective Assessment of Early Outcomes Following Thulium Fiber Laser Enucleation of the Prostate Using SOLTIVE™ SuperPulsed Laser Systems in an Asian Population

  • by Brian W.H. Siu, David K.W. Leung, Rachel S.K. Wong, Chris H.M. Wong, Alex Q. Liu, Chi Hang Yee, Jeremy Y.C. Teoh, Peter K.F. Chiu, Chi Fai Ng, Ka Lun Lo

  • March 30, 2026

Related Content

Single-port robotic-assisted radical prostatectomy: evaluating the Da Vinci SP system in minimally invasive urologic oncology

Development and validation of a nomogram for predicting early stress urinary incontinence following endoscopic enucleation of the prostate

Assessing peri-operative antibiotic administration practices amongst urologic surgeons performing holmium laser enucleation of the prostate worldwide